Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro.

in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology by Marc Lecoultre, Sylvie Chliate, Felipe I Espinoza, Stoyan Tankov, Valérie Dutoit, Paul R Walker

TLDR

  • The study investigates how radio-chemotherapy affects the immune response in glioblastoma (GBM) by looking at the role of macrophages in the GBM microenvironment. Macrophages are cells that can engulf and digest dead cells, and they can also communicate with other cells in the body. The study found that when GBM cells are treated with radio-chemotherapy, the macrophages become more active in engulfing and digesting the dead GBM cells. However, this increased activity can also lead to the macrophages becoming less effective at fighting the GBM. The study suggests that future research should explore ways to stop this process from happening, which could improve the immune response and help patients with GBM.

Abstract

Immunotherapy is actively explored in glioblastoma (GBM) to improve patient prognosis. Tumor-associated macrophages (TAMs) are abundant in GBM and harnessing their function for anti-tumor immunity is of interest. They are plastic cells that are influenced by the tumor microenvironment, by radio-chemotherapy and by their own phagocytic activity. Indeed, the engulfment of necrotic cells promotes pro-inflammatory (and anti-tumoral) functions while the engulfment of apoptotic cells promotes anti-inflammatory (and pro-tumoral) functions through efferocytosis. To model the effect of radio-chemotherapy on the GBM microenvironment, we exposed human macrophages to supernatant of treated GBM cells in vitro. Macrophages were derived from human monocytes and GBM cells from patient-resected tumors. GBM cells were exposed to therapeutically relevant doses of irradiation and chemotherapy. Apoptosis and phagocytic activity were assessed by flow cytometry. The phagocytic activity of macrophages was increased, and it was correlated with the proportion of apoptotic GBM cells producing the supernatant. Whether uptake of apoptotic tumor cells could occur would depend upon the expression of efferocytosis-associated receptors. Indeed, we showed that efferocytosis-associated receptors, such as AXL, were upregulated. We showed that macrophage phagocytic activity increased when exposed to supernatant from GBM cells treated by radio-chemotherapy. However, as efferocytosis-associated receptors were up-regulated, this effect could be deleterious for the anti-GBM immune response. We speculate that by inducing GBM cell apoptosis in parallel to an increase in efferocytosis receptor expression, the impact of radio-chemotherapy on phagocytic activity could promote anti-inflammatory and pro-tumoral TAM functions.

Overview

  • The study explores the effect of radio-chemotherapy on the GBM microenvironment using human macrophages exposed to supernatant from treated GBM cells in vitro. The study aims to understand the impact of radio-chemotherapy on phagocytic activity and its correlation with apoptosis of GBM cells. The hypothesis being tested is that radio-chemotherapy promotes anti-inflammatory and pro-tumoral TAM functions through efferocytosis. The methodology used for the experiment includes the derivation of human macrophages and GBM cells from patient-resected tumors, exposure of GBM cells to therapeutically relevant doses of irradiation and chemotherapy, and assessment of apoptosis and phagocytic activity by flow cytometry. The primary objective of the study is to understand the impact of radio-chemotherapy on phagocytic activity and its correlation with apoptosis of GBM cells.

Comparative Analysis & Findings

  • The study found that the phagocytic activity of macrophages was increased after exposure to supernatant from GBM cells treated by radio-chemotherapy. This increase was correlated with the proportion of apoptotic GBM cells producing the supernatant. However, the study also showed that efferocytosis-associated receptors, such as AXL, were upregulated, which could be deleterious for the anti-GBM immune response. The findings suggest that radio-chemotherapy promotes anti-inflammatory and pro-tumoral TAM functions through efferocytosis, which could have negative implications for the anti-GBM immune response.

Implications and Future Directions

  • The study highlights the importance of understanding the impact of radio-chemotherapy on the GBM microenvironment and its correlation with phagocytic activity and apoptosis of GBM cells. The findings suggest that radio-chemotherapy promotes anti-inflammatory and pro-tumoral TAM functions through efferocytosis, which could have negative implications for the anti-GBM immune response. Future research could explore the use of efferocytosis-inhibitors to enhance the anti-GBM immune response and improve patient prognosis. Additionally, the study could be expanded to include in vivo models to further investigate the impact of radio-chemotherapy on the GBM microenvironment and its correlation with phagocytic activity and apoptosis of GBM cells.